KRAS Oncoprotein Signaling in Cancer
P
Piro Lito
(From the Human Oncology and Pathogenesis Program and the Department of Medicine, Memorial Sloan Kettering Cancer Center, New York.)
Article Details
Journal
New England Journal of Medicine
Volume / Issue
Vol. 392, Issue 3
Published
January 16, 2025
Pages
296-298
ISSN
0028-4793
Publisher
Massachusetts Medical Society
Journal Info
New England Journal of Medicine
Massachusetts Medical Society
ISSN: 0028-4793 Social Sciences
Authors (1)
P
Piro Lito
From the Human Oncology and Pathogenesis Program and the Department of Medicine, Memorial Sloan Kettering Cancer Center, New York.
Related Articles from this Journal
Doctor’s Dirty Little Secret — The Cost of Silence
Tara Khan
Aug 2026
10.1056/nejmp2515506
Obstructive Hypertrophic Cardiomyopathy
Julian-Kai Nishizono, Marohito Nakata
Aug 2026
10.1056/nejmicm2603868
T-Cell Engager–Mediated HLA Antibody Depletion before Kidney Transplantation
Martina Schatzl, Katharina A. Mayer et al.
Jul 2026
10.1056/nejmc2603853
Products That Pose Health Risks — Can Litigation Protect Us When Government Fails?
Jerry Avorn
Jul 2026
10.1056/nejmp2604841
Precision Intensification in Metastatic Prostate Cancer
Rana R. McKay
Jul 2026
10.1056/nejme2605582